You are here: Industry Insights > COVID-19 vaccine

News List

No evidence of greater blood clot risk from vaccine: AstraZeneca expresspharma
March 16, 2021
Its review covered more than 17 million people vaccinated in the UK and EU and comes after health authorities in some countries suspended the use of its vaccine over clotting issues.
Update on the safety of COVID-19 Vaccine AstraZeneca worldpharmanews
March 15, 2021
Following a recent concern raised around thrombotic events, AstraZeneca would like to offer its reassurance on the safety of its COVID-19 vaccine based on clear scientific evidence.
Novavax vaccine shows 96 per cent efficacy against original coronavirus, 86 per cent against UK variant expresspharma
March 15, 2021
Novavax plans to produce its two-shot vaccine at eight manufacturing locations, including the Serum Institute of India.
J&J single-shot COVID-19 vaccine gets Emergency Use Listing by WHO expresspharma
March 15, 2021
Data have demonstrated vaccine protects against COVID-19 related hospitalisation and death in broad geographic regions, including those with variants of significant concern.
QUAD pledges to supply billion doses of COVID-19 vaccine across Asia by 2022 expresspharma
March 15, 2021
The leaders also agreed to set up an experts’ group to help distribute vaccines, as well as working groups on climate change, technology standards, and joint development of emerging technologies.
Antibodies generated by COVID-19 vaccines less effective against some variants: US Study expresspharma
March 15, 2021
According to the scientists, the two strains first described in Brazil and Japan were five to seven times more resistant, compared to the original SARS-CoV-2 virus lineage from Wuhan, China.
First patients receive Moderna’s modified COVID-19 vaccine candidates europeanpharmaceuticalreview
March 12, 2021
Moderna has begun testing two new mRNA COVID-19 vaccines, one specifically targeting the B.1.351 variant and the other a multivalent candidate.
New real-world evidence for Pfizer/BioNTech COVID-19 vaccine pharmatimes
March 12, 2021
New real-world evidence gathered by the Israel Ministry of Health (MoH) suggests that Pfizer/BioNTech’s COVID-19 vaccine ‘dramatically’ lowers the incidence rates of COVID-19 in fully vaccinated individuals.
EMA approves fourth Covid-19 vaccine, J&J’s single-shot candidate pharmaceutical-technology
March 12, 2021
The European Medicines Agency (EMA) has recommended conditional marketing authorisation for Johnson & Johnson (J&J) subsidiary Janssen’s Covid-19 vaccine.
Vir, GSK to seek EUA for COVID-19 antibody therapy expresspharma
March 12, 2021
Vir and GSK also said that a new laboratory study showed the therapy, VIR-7831, was equally effective against the UK, South African and Brazilian variants of the coronavirus.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page